Banner for leaf pages 2

Colesevelam (Welchol)

Also known as Welchol

Colesevelam is a bile acid sequestrant administered orally. It is developed by Genzyme and marketed in the US by Daiichi Sankyo under the brand name Welchol and elsewhere by Genzyme as Cholestagel. In Canada it is marketed by Valeant as Lodalis.

Source: Wikipedia

Estimated Total Cost: $158.51 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed colesevelam to treat hyperlipidemia, ischemic heart disease, acute kidney injury, and blastomycosis.

What side effects are related?

Patients taking colesevelam most commonly experience side effects like flatulence, constipation, and headache.

Ajax-loader Loading...